Viewing
|Articles|October 7, 2010

Highlights of dry eye Phase 2 clinical study revealed

ISTA Pharmaceuticals has highlighted results from its Phase 2 clinical study on Remura dry eye solution.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe

Latest CME